Laurel E. Williams

2.6k total citations
43 papers, 1.8k citations indexed

About

Laurel E. Williams is a scholar working on Pulmonary and Respiratory Medicine, Small Animals and Genetics. According to data from OpenAlex, Laurel E. Williams has authored 43 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Pulmonary and Respiratory Medicine, 17 papers in Small Animals and 14 papers in Genetics. Recurrent topics in Laurel E. Williams's work include Veterinary Oncology Research (33 papers), Infectious Diseases and Mycology (17 papers) and Virus-based gene therapy research (14 papers). Laurel E. Williams is often cited by papers focused on Veterinary Oncology Research (33 papers), Infectious Diseases and Mycology (17 papers) and Virus-based gene therapy research (14 papers). Laurel E. Williams collaborates with scholars based in United States, Canada and United Kingdom. Laurel E. Williams's co-authors include Antony S. Moore, Susan M. Cotter, Kenneth M. Rassnick, Jeffrey L. Johnson, Cheryl A. London, Marlene Hauck, Rebecca A. Packer, Angela E. Frimberger, David Ruslander and Donald Ε. Thrall and has published in prestigious journals such as Clinical Cancer Research, Ecological Economics and Journal of the American Veterinary Medical Association.

In The Last Decade

Laurel E. Williams

43 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Laurel E. Williams United States	25	1.5k	786	576	239	204	43	1.8k
Mary K. Klein United States	19	1.3k 0.9×	440 0.6×	475 0.8×	257 1.1×	109 0.5×	26	1.7k
Margaret C. McEntee United States	26	1.1k 0.8×	304 0.4×	439 0.8×	88 0.4×	83 0.4×	67	1.7k
Rodney C. Straw United States	33	2.1k 1.4×	467 0.6×	829 1.4×	134 0.6×	98 0.5×	65	3.0k
Gerald Post United States	18	648 0.4×	272 0.3×	226 0.4×	142 0.6×	49 0.2×	41	943
P. van Heerde Netherlands	31	1.2k 0.8×	277 0.4×	281 0.5×	485 2.0×	99 0.5×	62	3.2k
Ibrahim Ramzy United States	30	627 0.4×	62 0.1×	265 0.5×	109 0.5×	47 0.2×	117	2.7k
R Reid United Kingdom	20	490 0.3×	36 0.0×	151 0.3×	193 0.8×	113 0.6×	57	2.1k
Loren E. Golitz United States	27	232 0.2×	127 0.2×	192 0.3×	356 1.5×	19 0.1×	69	2.6k
Theo M. Starink Netherlands	25	322 0.2×	35 0.0×	290 0.5×	64 0.3×	44 0.2×	44	1.4k
Peter Vooijs Netherlands	24	170 0.1×	47 0.1×	150 0.3×	116 0.5×	43 0.2×	42	2.1k

Countries citing papers authored by Laurel E. Williams

Since Specialization

Citations

This map shows the geographic impact of Laurel E. Williams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laurel E. Williams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laurel E. Williams more than expected).

Fields of papers citing papers by Laurel E. Williams

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laurel E. Williams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laurel E. Williams. The network helps show where Laurel E. Williams may publish in the future.

Co-authorship network of co-authors of Laurel E. Williams

This figure shows the co-authorship network connecting the top 25 collaborators of Laurel E. Williams. A scholar is included among the top collaborators of Laurel E. Williams based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laurel E. Williams. Laurel E. Williams is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Fogle, Jonathan E., et al.. (2015). CD45+ and CD45− lymphocyte populations identified by flow cytometry from dogs with lymphoma exhibit similar morphology and the same clonal (B cell or T cell) lineage. Veterinary Immunology and Immunopathology. 168(3-4). 242–248. 6 indexed citations

2.

Williams, Laurel E., et al.. (2013). Lymphoma Immunophenotype of Dogs Determined by Immunohistochemistry, Flow Cytometry, and Polymerase Chain Reaction for Antigen Receptor Rearrangements. Journal of Veterinary Internal Medicine. 27(6). 1509–1516. 51 indexed citations

3.

McCleary‐Wheeler, Angela L., Laurel E. Williams, Paul R. Hess, & Steven E. Suter. (2010). Evaluation of an in vitro telomeric repeat amplification protocol assay to detect telomerase activity in canine urine. American Journal of Veterinary Research. 71(12). 1468–1474. 6 indexed citations

4.

Johnson, Jeffrey L., et al.. (2008). Adverse Effects of Concurrent Carboplatin Chemotherapy and Radiation Therapy in Dogs. Journal of Veterinary Internal Medicine. 23(1). 24–30. 18 indexed citations

5.

Duncan, Ashlee W., Henry S. Marr, Adam J. Birkenheuer, et al.. (2008). Bartonella DNA in the Blood and Lymph Nodes of Golden Retrievers with Lymphoma and in Healthy Controls. Journal of Veterinary Internal Medicine. 22(1). 89–95. 29 indexed citations

6.

Rassnick, Kenneth M., Laurel E. Williams, Orna Kristal, et al.. (2008). Lomustine for treatment of mast cell tumors in cats: 38 cases (1999–2005). Journal of the American Veterinary Medical Association. 232(8). 1200–1205. 28 indexed citations

7.

Vaughan, Andrew, Jeffrey L. Johnson, & Laurel E. Williams. (2007). Impact of Chemotherapeutic Dose Intensity and Hematologic Toxicity on First Remission Duration in Dogs with Lymphoma Treated with a Chemoradiotherapy Protocol. Journal of Veterinary Internal Medicine. 21(6). 1332–1339. 30 indexed citations

8.

Vaughan, Andrew, Jeffrey L. Johnson, & Laurel E. Williams. (2007). Impact of Chemotherapeutic Dose Intensity and Hematologic Toxicity on First Remission Duration in Dogs with Lymphoma Treated with a Chemoradiotherapy Protocol. Journal of Veterinary Internal Medicine. 21(6). 1332–1332. 33 indexed citations

9.

Williams, Laurel E., Kenneth M. Rassnick, Helen T. Power, et al.. (2006). CCNU in the Treatment of Canine Epitheliotropic Lymphoma. Journal of Veterinary Internal Medicine. 20(1). 136–143. 60 indexed citations

10.

Thrall, Donald Ε., Susan Μ. LaRue, Daohai Yu, et al.. (2005). Thermal Dose Is Related to Duration of Local Control in Canine Sarcomas Treated with Thermoradiotherapy. Clinical Cancer Research. 11(14). 5206–5214. 75 indexed citations

11.

Bailey, Dennis B., Hollis N. Erb, Laurel E. Williams, David Ruslander, & Marlene Hauck. (2003). Carboplatin and Doxorubicin Combination Chemotherapy for the Treatment of Appendicular Osteosarcoma in the Dog. Journal of Veterinary Internal Medicine. 17(2). 199–205. 60 indexed citations

12.

Rassnick, Kenneth M., Nicole C. Northrup, Orna Kristal, et al.. (2003). A combination chemotherapy protocol with MOPP and CCNU consolidation (Tufts VELCAP‐SC) for the treatment of canine lymphoma. Veterinary and Comparative Oncology. 1(4). 180–190. 44 indexed citations

13.

Proulx, David R., David Ruslander, Richard K. Dodge, et al.. (2003). A RETROSPECTIVE ANALYSIS OF 140 DOGS WITH ORAL MELANOMA TREATED WITH EXTERNAL BEAM RADIATION. Veterinary Radiology & Ultrasound. 44(3). 352–359. 119 indexed citations

14.

Moore, Antony S., Susan M. Cotter, William Rand, et al.. (2001). Evaluation of a Discontinuous Treatment Protocol (VELCAP-S) for Canine Lymphoma. Journal of Veterinary Internal Medicine. 15(4). 348–354. 86 indexed citations

15.

Rassnick, Kenneth M., Tracy L. Gieger, Laurel E. Williams, et al.. (2001). Phase I Evaluation of CCNU (Lomustine) in Tumor-Bearing Cats. Journal of Veterinary Internal Medicine. 15(3). 196–196. 39 indexed citations

16.

Rassnick, Kenneth M., Angela E. Frimberger, Carrie A. Wood, et al.. (2000). Evaluation of Ifosfamide for Treatment of Various Canine Neoplasms. Journal of Veterinary Internal Medicine. 14(3). 271–276. 24 indexed citations

17.

Rassnick, Kenneth M., et al.. (2000). Evaluation of Ifosfamide for Treatment of Various Canine Neoplasms. Journal of Veterinary Internal Medicine. 14(3). 271–271. 24 indexed citations

18.

Rassnick, Kenneth M., Antony S. Moore, Laurel E. Williams, et al.. (1999). Treatment of Canine Mast Cell Tumors with CCNU (Lomustine). Journal of Veterinary Internal Medicine. 13(6). 601–605. 99 indexed citations

19.

Moore, Antony S., Cheryl A. London, Carrie A. Wood, et al.. (1999). Lomustine (CCNU) for the Treatment of Resistant Lymphoma in Dogs. Journal of Veterinary Internal Medicine. 13(5). 395–398. 107 indexed citations

20.

Moore, Antony S., et al.. (1999). Lomustine (CCNU) for the Treatment of Resistant Lymphoma in Dogs. Journal of Veterinary Internal Medicine. 13(5). 395–395. 105 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact